Copy number loss of ARG2 and ASS1 genes are high in ccRCC patients (38% and 24%, respectively) and their combined loss connotes a nearly 3-year reduction in overall survival. The gene discussed is ASS1; the disease is nonpapillary renal cell carcinoma.